Earnings watch · BDX · Healthcare

Becton Dickinson and Company (BDX) sits just below fair value before earnings

The medical-technology stock has regained ground across weekly windows, but confirmation remains uneven before the Aug. 6 report.

Becton Dickinson and Company
Latest165.62 USD
1W move5.9%
Volume0.8x
TrendInactive
Becton Dickinson medical devices and diagnostic instruments beside a market data terminal.

Market update

What happened

Becton Dickinson and Company (BDX) last closed at 165.62 USD ahead of its Aug. 6 earnings date. The earnings calendar lists a 3.14 USD estimate for the fiscal period ended June 30.

The weekly backdrop has improved, with gains of 5.9% over one week, 4.8% over four weeks and 11.6% over twelve weeks. The read is still mixed: the trend signal is inactive, Relative Strength is -0.4, and Market Dynamics shows modest positive pressure at 0.31.

Continue your research

Explore BDX across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

Medical Instruments & Supplies coverage

Evidence context